Journal article
14 Antithrombotic treatment of cerebrovascular disease
Abstract
The most common type of cerebrovascular disease is ischaemia or infarction from atherothrombosis or cardiac embolism. Antithrombotic treatment with an antiplatelet agent or anticoagulant assumes a prior clinical classification into categories of transient ischaemic attack (TIA) or minor stroke, acute partial stable stroke, stroke-in-progression, and completed stroke. Aspirin reduces the risk of stroke, myocardial infarction, and death after TIA …
Authors
Oczkowski WJ; Turpie AGG
Journal
Best Practice & Research Clinical Haematology, Vol. 3, No. 3, pp. 781–813
Publisher
Elsevier
Publication Date
July 1990
DOI
10.1016/s0950-3536(05)80028-9
ISSN
1521-6926
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AnticoagulantsAtrial FibrillationCerebrovascular DisordersCombined Modality TherapyDouble-Blind MethodDrug EvaluationDrug SynergismDrug Therapy, CombinationEndarterectomyEuropeFibrinolytic AgentsHeart Valve DiseasesHeart Valve ProsthesisHumansIschemic Attack, TransientNorth AmericaPlatelet Aggregation InhibitorsThrombolytic Therapy